mediven® angio Knee Compression Stocking Black Short Foot CCL1
The mediven® angio is a specialised medical compression stocking designed for patients with chronic venous disease and concomitant mild-to-moderate peripheral arterial disease (PAD) or diabetes mellitus. Clinically proven to provide effective compression therapy while accommodating arterial and sensory concerns.
- Compression Class 1 (CCL1) graduated compression
- Knee length, closed toe, Black — Short Foot (shoe size EU 36–40, foot length <25cm)
- Merino-plush padding in entire foot area to reduce pressure peaks and prevent lesions at bony predilection points
- Extra-long and flat knitted toe seam to avoid pressure on sensitive toes
- Soft, wide cuff — no constriction at the knee
- Clinically proven safe for venous disease with concomitant PAD and/or diabetes
Indications: Chronic venous disorders with concomitant mild-to-moderate PAD (ABPI 0.5–0.8), diabetic peripheral polyneuropathy, venous oedema in patients with arterial compromise.
Original: $93.74
-65%$93.74
$32.81Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
The mediven® angio is a specialised medical compression stocking designed for patients with chronic venous disease and concomitant mild-to-moderate peripheral arterial disease (PAD) or diabetes mellitus. Clinically proven to provide effective compression therapy while accommodating arterial and sensory concerns.
- Compression Class 1 (CCL1) graduated compression
- Knee length, closed toe, Black — Short Foot (shoe size EU 36–40, foot length <25cm)
- Merino-plush padding in entire foot area to reduce pressure peaks and prevent lesions at bony predilection points
- Extra-long and flat knitted toe seam to avoid pressure on sensitive toes
- Soft, wide cuff — no constriction at the knee
- Clinically proven safe for venous disease with concomitant PAD and/or diabetes
Indications: Chronic venous disorders with concomitant mild-to-moderate PAD (ABPI 0.5–0.8), diabetic peripheral polyneuropathy, venous oedema in patients with arterial compromise.
